the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

* View All Categories

Biotechnology Market Research

Biogenerics, World Market
<< Previous Page:   5   6   7   8   9   10   11   12   13   14   15   16   Next >>

Reports

Biogenerics
Published : 2006/07
The report provides separate comprehensive analytics for the US, Europe, and Rest of World. ...

Drug Discovery Technologies
Published : 2006/07
This report analyzes the worldwide markets for Drug Discovery Technologies in Millions of US$. ...

Drug Targets for Breast Cancer
Published : 2006/07
Breast cancer is a complex heterogeneous disease characterized by uncontrolled growth and spread of abnormal cells. It is also very prevalent, with reports from the World Health Organization estimating that more than 1.2 million people will be diagnosed w ...

Emerging Diagnostic Biomarkers in Ovarian Cancer
Published : 2006/07
In this report, we examine the pathophysiology of CaO and describe current methods of screening for the cancer. ...

European Immunodiagnostics Automation Markets
Published : 2006/07
This Frost & Sullivan research service titled European Immunodiagnostics Automation Markets provides an overview of the markets, along with revenue forecasts. ...

Influencing Brand Preferences in the Flow Cytometry
Published : 2006/07
The findings from this report will help suppliers better understand how their products are used and what types of flow cytometry reagents and instruments their customers require. ...

Mentor Medical Device Company Intelligence Report
Published : 2006/07
Mentor Corporation, headquartered in Santa Barbara, California, USA, develops, manufactures and markets products for plastic and reconstructive surgery. Until recently, Mentor also had a strong position in the urology market but, in June 2006, sold its Su ...

The Future of Monoclonal Antibodies Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011
Published : 2006/07
A key theme of this report is the high level of innovation, as demonstrated by advancements in antibody engineering with the introduction of chimeric, humanized and fully human mAbs. ...

A Guide to Business and Regulatory Strategies for Companion Diagnostics and Individual Therapies
Published : 2006/06
This report is a unique compilation of historical companion diagnostic products, business models for drug/diagnostic collaborations, education & marketing, intellectual property, regulatory, and reimbursement information for those interested in developing ...

Biodisposables: Utility and Technological Advances
Published : 2006/06
D&MD's Growth and Technological Advances of the Biodisposables Market is valuable tool. ...

Biogenerics 2006: Challenges ahead for an emerging market
Published : 2006/06
This report aims to explain the regulatory and scientific issues that will influence the success of biogenerics, as well as discuss the current trends and opinions within the industry. ...

Bioinformatics Markets
Published : 2006/06
The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. ...

Biotech 2010
Published : 2006/06
The area most likely to see strong growth in the next five years involves collaborations between large and small companies. ...

Can Pathway-Based Approaches Overcome the Problems of Target-Based Drug Discovery?
Published : 2006/06
In this report, we discuss recent progress in pathway-based drug discovery. ...

Chronic Lymphocytic Leukemia: Monoclonal Antibodies Will Drive Steady Growth
Published : 2006/06
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. ...

Commercial Insight: Transplantation
Published : 2006/06
The market for immusuppresssants used in transplantation is set to grow to $4.3 billion by 2015s. Despite changing protocols, the leading drug class by value should continue to be calcineurin inhibitors with a 37% market share, followed by mTOR inhibitors ...

D&MD's Peptides 2006: New Applications in Discovery, Manufacturing, and Therapeutics
Published : 2006/06
To date, three types of molecules have been developed for the treatment of human diseases. ...

Enzyme Inhibitors with Broad Therapeutic Applications
Published : 2006/06
This report offers a broad detailed overview of enzyme inhibitors currently on the market and those in late-stage clinical trials. ...

European Molecular Diagnostics Markets
Published : 2006/06
This analysis is available through our Drug Discovery Technologies Growth Partnership Services program. With this program, clients receive industry-leading market research. ...

European Orthopaedic Biomaterials Markets
Published : 2006/06
This Frost & Sullivan research service titled European Orthopedic Biomaterials Markets provides an overview of key market challenges and drivers. ...

Has Genomics Failed to Deliver?
Published : 2006/06
Following its conception more than a decade ago, the field of genomics excited the research community with the possibility of a faster, surer route to drug discovery, but this optimism has quickly faded and the industry is reassessing its prospects. ...

High-Content Screening for Target Identification and Validation
Published : 2006/06
This Report provides an overview of developments in the pharmaceuticals and clinical diagnostics industry, along with key drivers, influencing market factors, challenges, and analysis of trends recently witnessed. ...

High-Level Systems Biology Modeling in Drug Development
Published : 2006/06
This Health Industry Insights report examines the state of high-level systems biology modeling adoption ...

How Are Translational Medicine Biomarkers Impacting Industry?
Published : 2006/06
This report looks at the modernization of the drug development process through widespread adoption of translational studies using biomarkers. ...

Marketing and Sales Organization Best Practices for Biotech and Specialized Pharma
Published : 2006/06
In this report, we present the results of a study we performed in Europe in 2005 to identify best practices in marketing and sales strategies among high-performing and profitably growing biotech and midsize specialized pharmaceutical companies. ...

Nanobiotechnology
Published : 2006/06
This report analyzes the worldwide markets for Nanobiotechnology in US$ Million. The major product segments analyzed are Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, and Nanotubes and Fullerenes), and ...

Nanomedicine 2006-2011
Published : 2006/06
The purpose of this visiongain report is to examine the commercial prospects of nanotechnology in medicine - the fast-developing and increasingly lucrative field of nanomedicine. ...

Nucleic Acid Isolation Markets in Europe
Published : 2006/06
This analysis is available through our Drug Discovery Technologies Growth Partnership Service program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive feature ...

Nucleic Acid Testing Markets in China
Published : 2006/06
This Frost & Sullivan research service entitled Nucleic Acid Testing Markets in China gives an overview of the current status of the nucleic acid testing market in China and discusses present and potential revenues. ...

Nucleic Acid Testing Markets in Hong Kong
Published : 2006/06
This Frost & Sullivan research service entitled Nucleic Acid Testing Markets in Hong Kong gives an overview of the current status of the nucleic acid testing market in Hong Kong and discusses present and potential revenues. ...

Nucleic Acid Testing Markets in Taiwan
Published : 2006/06
This Frost & Sullivan research service entitled Nucleic Acid Testing Markets in Taiwan gives an overview of the current status of the nucleic acid testing market in Taiwan and discusses present and potential revenues. ...

Stakeholder Opinions: Systemic Lupus Erythematosus - On the Verge of a Breakthough
Published : 2006/06
Systemic Lupus Erythematosus is a chronic, life-long and potentially fatal autoimmune disease characterized by multiple system distress and unpredictable flares. ...

The Market for Antibodies: Keys to Success for Commerical Suppliers, Volume II
Published : 2006/06
BioInformatics LLC surveyed nearly 1,000 life scientists worldwide about the types of catalog antibodies that they use and their opinions of commercial suppliers. ...

The Protein Therapeutics Market: The Science and Business of a Growing Sector
Published : 2006/06
The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. ...

The Role of Pharmacogenomics in Personalized Medicine
Published : 2006/06
In this report, we examine how the use of pharmacogenomics will affect today's drug development strategies. ...

U.S. and Western European In Silico ADME/Toxicology Products Market
Published : 2006/06
The U.S. and Western European In Silico ADME/Tox Products report is presented as a Microsoft PowerPoint presentation (>180 slides) and contains several figures and tables that are ideal for marketing purposes. ...

U.S. Life Science Mass Spectrometry Markets
Published : 2006/06
This Frost & Sullivan research service entitled U.S. Life Science Mass Spectrometry Market provides a market forecast for mass spectrometers, taking into account two or three items that are included in the study. ...

US Markets for Soft Tissue Repair 2006
Published : 2006/06
This report provides the research about US soft tissue repair market. ...

An Evaluation of Products and Technologies for Molecular Diagnostics within Oncology "
Published : 2006/05
An overview of current industry-landscape for molecular diagnostics within the oncology area ...

'Big Pharma' Turns to Biologics for Growth to 2010: Financial and strategic segmentation of the 'Big Pharma' sector by drug technology
Published : 2006/05
...

Biotech in Autoimmune and Inflammatory Disease 2006, 2nd Edition
Published : 2006/05
The value of biological drugs indicated for autoimmune diseases, which affect up to 5% of the total world population, was roughly $11 billion in 2005. ...

Cancer Biomarkers: Enhancing diagnostic, therapeutic and developmental strategies
Published : 2006/05
The current focus on biomarker discovery is a result of an improved understanding of the biologic basis for carcinogenesis. ...

Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics
Published : 2006/05
This report provides Biomakers Commercial Opportunities Market Research, Trends, Analysis. ...

Directed Molecular Evolution: Product lifecycle management for biologics
Published : 2006/05
Biologics are forecast to be the fastest growing segment of the pharmaceutical market out to 2010 (12.2% CAGR). ...

Kinase Therapeutics:A Wealth of Targets Sparks a Highly Active Market
Published : 2006/05
Kinase Therapeutics: A Wealth of Targets Sparks a Highly Active Market reviews the considerable array of drug development efforts directed at kinases. ...

Maximizing Market Share Through Brand Differentiation
Published : 2006/05
This report provides suppliers with a frank and unbiased assessment of how their customers perceive their corporate brands compared to competing corporate brands. ...

Medical and Biological Sensors and Sensor Systems: Markets, Applications, and Competitors Worldwide, 2nd Edition
Published : 2006/05
The commercial world of medical sensors is vibrant and evolving rapidly. ...

Micro- and Nano-Medicine: Technologies, Applications, Industry, and Markets Worldwide
Published : 2006/05
This report is a detailed assessment of the products and technologies under development in the nanometer scale and micrometer scale levels with clinical applications, and an assessment of the market potential for products/technologies to be successfully c ...

Microdosing in Translational Medicine: Pros and Cons
Published : 2006/05
Microdosing in Translational Medicine: Pros and Cons evaluates this innovative approach to investigating candidate molecules. ...

Nucleic Acid Testing Markets (Malaysia) (2005-2010)
Published : 2006/05
This Frost & Sullivan research service entitled Nucleic Acid Testing Markets in Malaysia gives an overview of the current status of the nucleic acid testing market in Malaysia and discusses present and potential revenues. ...


<< Previous Page:   5   6   7   8   9   10   11   12   13   14   15   16   Next >>

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.